Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Collections
      • Disparities Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Collections
      • Disparities Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
Research Articles

Effects of Raloxifene on Circulating Prolactin and Estradiol Levels in Premenopausal Women at High Risk for Developing Breast Cancer

Jessica M. Faupel-Badger, Sheila A. Prindiville, David Venzon, Barbara K. Vonderhaar, Jo Anne Zujewski and Jennifer Eng-Wong
Jessica M. Faupel-Badger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheila A. Prindiville
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Venzon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara K. Vonderhaar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jo Anne Zujewski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Eng-Wong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-05-0898 Published June 2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: June 2006 to December 2019

AbstractFull-text HTMLPDF
Total207154601525

Cited By

Article Information

Volume 15, Issue 6, pp. 1153-1158

DOI 
https://doi.org/10.1158/1055-9965.EPI-05-0898
PubMed 
16775175

Published By 
American Association for Cancer Research
Print ISSN 
1055-9965
Online ISSN 
1538-7755
History 
  • Accepted March 30, 2006
  • Received November 28, 2005
  • Revision received March 2, 2006
  • Published first June 14, 2006.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Jessica M. Faupel-Badger1,2,
  2. Sheila A. Prindiville3,
  3. David Venzon4,
  4. Barbara K. Vonderhaar2,
  5. Jo Anne Zujewski5 and
  6. Jennifer Eng-Wong5
  1. 1Division of Cancer Prevention, 2Mammary Biology and Tumorigenesis Laboratory, 3Genetics Branch, 4Biostatistics and Data Management Section, and 5Medical Oncology Clinical Research Unit, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
  1. Requests for reprints:
    Jessica M. Faupel-Badger, Mammary Gland Biology and Tumorigenesis Laboratory, National Cancer Institute, Building 37, Room 1106, 37 Convent Drive, Bethesda, MD 20892-4254. Phone: 301-443-3076; Fax: 301-402-0711. E-mail: badgerje{at}mail.nih.gov
View Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 15 (6)
June 2006
Volume 15, Issue 6
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effects of Raloxifene on Circulating Prolactin and Estradiol Levels in Premenopausal Women at High Risk for Developing Breast Cancer
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
Citation Tools
Effects of Raloxifene on Circulating Prolactin and Estradiol Levels in Premenopausal Women at High Risk for Developing Breast Cancer
Jessica M. Faupel-Badger, Sheila A. Prindiville, David Venzon, Barbara K. Vonderhaar, Jo Anne Zujewski and Jennifer Eng-Wong
Cancer Epidemiol Biomarkers Prev June 1 2006 (15) (6) 1153-1158; DOI: 10.1158/1055-9965.EPI-05-0898

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Effects of Raloxifene on Circulating Prolactin and Estradiol Levels in Premenopausal Women at High Risk for Developing Breast Cancer
Jessica M. Faupel-Badger, Sheila A. Prindiville, David Venzon, Barbara K. Vonderhaar, Jo Anne Zujewski and Jennifer Eng-Wong
Cancer Epidemiol Biomarkers Prev June 1 2006 (15) (6) 1153-1158; DOI: 10.1158/1055-9965.EPI-05-0898
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Associations of Tobacco and Alcohol with SINT Risk in Utah
  • A Prognostic ATG-Based Scoring System in Ovarian Cancer
  • Antiparietal Cell Antibody and Esophageal and Gastric Cancer
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement